Skip to content
Stop using now Drug recall · FDA · Published March 11, 2021

Sagent Recalls Phenylephrine HCl Injection Due to Sterility Risk

Sagent Pharmaceuticals recalls specific lots of Phenylephrine HCl Injection due to lack of sterility assurance from loose crimped vial overseals.

🇺🇸 FDA recall #D-0305-2021DrugSagent Pharmaceuticals ›
Take action

Contact the company

Recalling firmSagent Pharmaceuticals Inc1901 N Roselle Rd Ste 450 · Schaumburg, IL 60195-3194
✎ GovInfoNow plain-language explainer

What happened, in plain English

Sagent Pharmaceuticals Inc has recalled Phenylephrine HCl Injection, USP, 10 mg per mL, packaged in single-dose vials. The recall addresses customer complaints regarding loose crimped vial overseals, which may result in the product being non-sterile. This affects specific lots distributed nationwide in the USA and Puerto Rico. Read more at govinfonow.com/recall/36482-sagent-recalls-phenylephrine-hcl-injection-due-to-sterility-risk.

Source Summary by GovInfoNow · govinfonow.com/recall/36482-sagent-recalls-phenylephrine-hcl-injection-due-to-sterility-risk · Updated October 11, 2026 · FDA enforcement record: FDA #D-0305-2021

Cite this page

“Sagent Recalls Phenylephrine HCl Injection Due to Sterility Risk.” GovInfoNow, updated October 11, 2026. https://govinfonow.com/recall/36482-sagent-recalls-phenylephrine-hcl-injection-due-to-sterility-risk. Based on FDA recall #D-0305-2021 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0305-2021%22&limit=1).

Why it’s dangerous

The vial overseals may be loose due to crimping issues, which compromises the seal. This lack of assurance of sterility means the injection could contain harmful contaminants, posing a serious health risk if administered intravenously.

Who’s affected

Patients or healthcare providers who purchased Phenylephrine HCl Injection from Sagent Pharmaceuticals between the manufacturing dates and expiration dates listed below, specifically those in the USA and Puerto Rico. Individuals using these specific lots are at risk of exposure to non-sterile medication.

How to tell if you have this one

Check for Phenylephrine HCl Injection, USP, 10 mg per mL, in single-dose vials packaged in cartons of 25. Look for NDC 25021-315-01 and the following lots with their expiration dates: PHT8IB2 (exp 08/2022), PHT9IB2 (exp 08/2022), and PHT1JB2 (exp 09/2022). The product is marked 'For Intravenous Use, Rx only' and manufactured for Sagent Pharmaceuticals in Schaumburg, IL.

  • Brand
    Sagent Pharmaceuticals
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Stop using the product

    Do not use any Phenylephrine HCl Injection from the recalled lots due to sterility concerns.

  2. Contact your provider

    Consult with a healthcare professional or pharmacist regarding alternative treatments if you have used or possess the affected product.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFLPuerto Rico: yesPR

FDA distribution: “Nationwide in the USA and Puerto Rico” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 22 months after the firm started it.

1. Firm started the recall: Mar 11, 202112. FDA classified it Class II: Mar 17, 202123. Published in FDA’s Enforcement Report: Mar 24, 202134. FDA terminated the recall: Dec 28, 2022420212022
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

✎ GovInfoNow

Questions people ask

What is the NDC number for the recalled product?

The National Drug Code (NDC) for the affected product is 25021-315-01.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0305-2021 (March 11, 2021) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0305-2021 to see it in context.
  • Plain-language summary written by qwen3.6:35b-a3b on October 11, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA